These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 25384555)
1. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease. Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555 [TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768 [TBL] [Abstract][Full Text] [Related]
3. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281 [TBL] [Abstract][Full Text] [Related]
4. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients. Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years. Ota K; Takeuchi T; Kojima Y; Sugawara N; Nishida S; Iwatsubo T; Kawaguchi S; Harada S; Tokioka S; Higuchi K BMC Gastroenterol; 2021 Nov; 21(1):432. PubMed ID: 34794376 [TBL] [Abstract][Full Text] [Related]
6. Endotherapy for and tailored approaches to treating GERD, and refractory GERD. Locke GR; Horwhat J; Mashimo H; Savarino E; Zentilin P; Savarino V; Zerbib F; Armbruster SP; Wong RK; Moawad F Ann N Y Acad Sci; 2013 Oct; 1300():166-186. PubMed ID: 24117641 [TBL] [Abstract][Full Text] [Related]
7. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure. Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486 [TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [TBL] [Abstract][Full Text] [Related]
9. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Frazzoni M; Conigliaro R; Manta R; Melotti G Aliment Pharmacol Ther; 2011 Jul; 34(1):67-75. PubMed ID: 21539587 [TBL] [Abstract][Full Text] [Related]
10. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor. Mine S; Iida T; Tabata T; Okada Y; Tanaka Y J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn. Schwameis K; Oh D; Green KM; Lin B; Zehetner J; Lipham JC; Hagen JA; DeMeester SR Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31942976 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Zacherl J; Roy-Shapira A; Bonavina L; Bapaye A; Kiesslich R; Schoppmann SF; Kessler WR; Selzer DJ; Broderick RC; Lehman GA; Horgan S Surg Endosc; 2015 Jan; 29(1):220-9. PubMed ID: 25135443 [TBL] [Abstract][Full Text] [Related]
13. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease. Watson TJ; Peters JH Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131 [TBL] [Abstract][Full Text] [Related]
14. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599 [TBL] [Abstract][Full Text] [Related]
16. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease. Rohof WO; Bennink RJ; de Jonge H; Boeckxstaens GE Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1647-55. PubMed ID: 24184737 [TBL] [Abstract][Full Text] [Related]
17. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Barnes WE; Hoddinott KM; Mundy S; Williams M Surg Innov; 2011 Jun; 18(2):119-29. PubMed ID: 21307014 [TBL] [Abstract][Full Text] [Related]
18. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439 [TBL] [Abstract][Full Text] [Related]
20. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Noar MD; Noar E Surg Endosc; 2008 Nov; 22(11):2440-4. PubMed ID: 18437485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]